How We Can Support the Drug Development Pipeline

Source BioScience provides a comprehensive suite of services supporting all aspects of the drug development pathway from target identification, validation and clinical trials, as well as the development of companion diagnostics to support new drug launches.

Our expertise in pharmacogenomics provides an insight into gene expression and how variations in DNA can affect response to drugs. These effects can be toxic and harmful to the patient, or render drug therapy useless. Gene expression analysis can be used as an indicator for patient response to treatment and can aid in the development of personalised medicine providing more effective drug therapy to the patient.

Our experience and comprehensive services offered provide tools to shorten drug development time and cut costs enabling pharmaceutical and biotech companies to meet tough deadlines.

Our bioinformatics capabilities allow drug companies and researchers to look at cell signalling pathways to analyse effects of new drugs, and can help to determine synergistic or antagonistic combinations which may be important for FDA submission studies.

All services are carried out by molecular scientists and principal investigators with many years experience in the field of molecular medicine, tissue biomarker based research and genomics.

Source BioScience is a GLP,GCP,CPA accredited and CLIA compliant company with many years experience of working with Pharmaceutical and Biotech companies globally, as well as clinical research organisations. The company has strong links with academia, with lab facilities in Cambridge, Oxford, Nottingham, London and Dublin